the antiarrhythmic efficacy and pharmacokinetics of n-acetylprocainamide ( napa ) , the major metabolite of procainamide , were investigated in 23 patients with chronic , high frequency ventricular ectopic depolarizations .
C0003195
antiarrhythmic
C0033216
procainamide